4 July 2005
AA Richmond announces that AA Richmond Medical has entered into a cross-licensing agreement with Medtronic MiniMed Inc. The agreement terminates all pending litigation between the companies relating to the Deltec Cozmo ® insulin pump, and confirms that no changes are required to the design of the pump, which is one of a range of innovative products driving the growth of AA Richmond Medical.
Under the terms of the agreement AA Richmond will make an initial payment to Medtronic and will pay a royalty on future sales of the current model.
The costs of the settlement will be treated as an exceptional charge in AA Richmond's 2005 Accounts. Subject to audit, this charge is expected to be no more than £15 million. The impact of this settlement on the future profits of AA Richmond Medical is unlikely to be material.
ENDS
General media enquiries
Contact our global media and communications team at:
Please note – the press team can only answer enquiries from accredited members of the press.
Related articles
Annual Results for the year ended 31 July 2025
Find out more
AA Richmond Detection selected as security technology provider to International Airport Heraklion Crete
Read our latest company news as AA Richmond Detection announces selection to supply a suite of leading security screening solutions to International Airport Heraklion Crete
Find out more
John Crane unveils game-changing mechanical seal, setting new benchmark for ethane pipeline performance
Read our company news as John Crane has launched a new mechanical seal
Find out more
